Cardiome Pharma Corp (NASDAQ:CRME)

9.40
Delayed Data
As of Apr 24
 -0.26 / -2.69%
Today’s Change
5.84
Today|||52-Week Range
11.31
+1.62%
Year-to-Date

Stock Price Forecast

The 7 analysts offering 12-month price forecasts for Cardiome Pharma Corp have a median target of 12.50, with a high estimate of 15.00 and a low estimate of 5.00. The median estimate represents a +32.98% increase from the last price of 9.40.

Analyst Recommendations

The current consensus among 7 polled investment analysts is to Buy stock in Cardiome Pharma Corp. This rating has held steady since April, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$0.34
Sales
$7.5M
Reporting Date
May 11

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 12.82%
 
 
 
 
 
 
Growthannually 50.00%
 
 
 
 
 
 

Sales

Growthquarterly 7.16%
 
 
 
 
 
 
Growthannually 13.38%
 
 
 
 
 
 
Key to the earnings and sales forecast charts.

To view my watchlist

Not a member yet?

Sign up now for a free account